Aspira Women's Health Inc.
NASDAQ: AWH0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Medical - Diagnostics & Research
- CEO
- Nicolette Possemato
- Employees
- 66
- Headquarters
- Austin, United States
- IPO year
- 2000
- Market cap
- $2.5M
- Website
- https://aspirawh.com
Loading AWH…
Loading profile data…Frequently asked questions about AWH
What does Aspira Women's Health Inc. (AWH) do?
Aspira Women's Health Inc., alongside its subsidiaries, specializes in the development and commercialization of diagnostic tools for gynecologic diseases across the United States. Their product portfolio includes tests such as OVA1, OVERA, and OVA1plus, designed to evaluate the risk of ovarian malignancy in women presenting with adnexal masses....
Where does AWH trade?
Aspira Women's Health Inc. (AWH) trades on the NASDAQ Capital Market.
What sector is AWH in?
Aspira Women's Health Inc. (AWH) operates in the Healthcare sector, specifically in the Medical - Diagnostics & Research industry.
Who is the CEO of Aspira Women's Health Inc.?
Nicolette Possemato is the chief executive officer of Aspira Women's Health Inc. (AWH).
Where is Aspira Women's Health Inc. headquartered?
Aspira Women's Health Inc. is headquartered in United States.
Does AWH pay a dividend?
Aspira Women's Health Inc. (AWH) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AWH go public?
Aspira Women's Health Inc. (AWH) completed its initial public offering in 2000.